project id: TCGA-OV; case submitter id: TCGA-61-2017; selected normal wgs: true; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.2; rna integrity number: 7.6; spectrophotometer method: UV Spec; age at index: 64; days to birth: -23509; ethnicity: not reported; gender: female; race: white; vital status: Alive; year of birth: 1941; age at diagnosis: 23509; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1398.0; figo stage: Stage IIIC; icd 10 code: C56.9; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ovary; synchronous malignancy: Not Reported; tissue or organ of origin: Ovary; tumor grade: Not Reported; year of diagnosis: 2005; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; intermediate dimension: 0.7; longest dimension: 0.8; preservation method: Unknown; shortest dimension: 0.3; sample id: 9c2c353b-dff6-4a94-8e21-741641cd6c4c; sample submitter id: TCGA-61-2017-01A; portion id: 4d04cba7-11fd-4ca1-a82b-651d6e3474e7; portion submitter id: TCGA-61-2017-01A-01; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor nuclei: 95.0;